FDA Inspection 1299288 — LPNA Group Inc.
The FDA completed an inspection of LPNA Group Inc. on January 21, 2026 in Tonawanda, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 21, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Tonawanda, NY (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 2419 | 21 CFR 211.198(a) | Complaint Handling Procedure |
| 3602 | 21 CFR 211.160(a) | Deviations from laboratory control requirements |
| 4391 | 21 CFR 211.180(e)(2) | Items to cover on annual reviews |